Xenon Pharmaceuticals XENE Total Current Liabilities
Total Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Xenon Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.
The official record: Xenon Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Xenon Pharmaceuticals's total current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Xenon Pharmaceuticals's total current liabilities?
- Xenon Pharmaceuticals (XENE) reported total current liabilities of $39.82M in Q1 2026.
- How has Xenon Pharmaceuticals's total current liabilities changed year-over-year?
- Xenon Pharmaceuticals's total current liabilities increased by 24.3% year-over-year, from $32.03M to $39.82M.
- What is the long-term trend for Xenon Pharmaceuticals's total current liabilities?
- Over 5 years (2020 to 2025), Xenon Pharmaceuticals's total current liabilities has grown at a 23.1% compound annual growth rate (CAGR), from $14.78M to $41.79M.
- What does total current liabilities mean?
- The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.